Frontiers

Humoral immune response to COVID-19 vaccines in onchocerciasis-infected individuals: a field study from Ghana

Introduction: COVID-19 vaccines are the most successful medical interventions to reduce disease severity and mortality. Various vaccine platforms with unique properties have been developed. The course ...
Morningstar

Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan to increase ...

QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from concept to commercialization FORT LEE, N.J., Sept. 29, 2025 /PRNewswire/ -- ...
Frontiers

Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors

Introduction: Despite SARS-CoV-2 pandemic has subsided, vaccine response profiling in patients with cancer remains critical. Methods: We longitudinally assessed humoral and cellular immunity in adults ...
gla.ac.uk

Professor Nicola Veitch delivers inaugural lecture

The inaugural lecture of Nicola Veitch, Professor of Bioscience Education and Parasitology in the School of Infection & Immunity, took place on Thursday, 11 September 2025. Hosted by Sii and the ...